Lv1
65 积分 2021-10-17 加入
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
8个月前
已完结
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
8个月前
已完结
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
9个月前
已完结
Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China
9个月前
已完结
Suicide prevention among patients with cancer
10个月前
已完结
Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study
10个月前
已关闭
Prediction of risk of suicide death among lung cancer patients after the cancer diagnosis
10个月前
已完结
Suicide risk after head and neck cancer diagnosis in Taiwan: A retrospective cohort study
10个月前
已完结
A prospective study comparing the gasless endoscopic thyroidectomy trans-axillary approach to conventional open thyroidectomy: health and quality of life outcomes
11个月前
已完结
Ansa Cervicalis External Branch Anastomosis to Restore High Tone Voice in Thyroid Surgery
11个月前
已完结
皖公网安备34019202002308
